Safety and efficacy of tegaserod therapy in patients with irritable bowel syndrome or chronic constipation.

Al-Judaibi, B; Chande, N; Gregor, Jc

Al-Judaibi, B; Chande, N; Gregor, Jc.

Affiliation

Al-Judaibi B; Division of Gastroenterology, University of Western Ontario, London, Canada. baljuda@uwo.ca

Can J Clin Pharmacol ; 17(1): e194-200, 2010.

Article in En | MEDLINE | ID: mdl-20410554

Subject(s)

Constipation/drug therapy; Indoles/therapeutic use; Irritable Bowel Syndrome/drug therapy; Adult; Aged; Aged, 80 and over; Cardiovascular Diseases/chemically induced; Cardiovascular Diseases/epidemiology; Chronic Disease; Constipation/diagnosis; Diarrhea/chemically induced; Diarrhea/epidemiology; Female; Follow-Up Studies; Humans; Indoles/adverse effects; Irritable Bowel Syndrome/diagnosis; Male; Middle Aged; Receptors, Serotonin, 5-HT4/physiology; Risk Factors; Safety; Treatment Outcome; Young Adult

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Constipation / Irritable Bowel Syndrome / Indoles Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Can J Clin Pharmacol Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2010 Document type: Article Affiliation country: Canada Country of publication: Canada

Search on Google

Add to My VHL

XML

PubMed Links